Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoringH Openshaw, B T Lund, A Kashyap, et al.
Transfusion|April 16, 1999
Frequency of immediate adverse effects associated with therapeutic apheresisB C McLeod, I Sniecinski, D Ciavarella, et al.
Transfusion|October 13, 1998
Frequency of immediate adverse effects associated with apheresis donationB C McLeod, T H Price, H Owen, et al.
Blood|June 15, 1997
Hematopoietic potential and retroviral transduction of CD34+ Thy-1+ peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factorU Junker, J J Moon, C S Kalfoglou, et al.
Blood|January 1, 1986
Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantationJ Hows, K Beddow, E Gordon-Smith, et al.
Experimental Hematology|September 5, 1998
Comparison of amphotropic and pseudotyped VSV-G retroviral transduction in human CD34+ peripheral blood progenitor cells from adult donors with HIV-1 infection or cancerP Y Yam, J K Yee, J I Ito, et al.
Blood|September 1, 1992
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot studyA Nademanee, G M Schmidt, M R O'Donnell, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Phase I trial of interleukin-2 plus gamma-interferonK A Margolin, J H Doroshow, S A Akman, et al.
Cancer Research|August 1, 1988
Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humansD H Boldt, B J Mills, B T Gemlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cellsA Nademanee, I Sniecinski, G M Schmidt, et al.
Pageof 3